Michael Durante

2.3k total citations · 1 hit paper
33 papers, 1.1k citations indexed

About

Michael Durante is a scholar working on Molecular Biology, Ophthalmology and Oncology. According to data from OpenAlex, Michael Durante has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Ophthalmology and 11 papers in Oncology. Recurrent topics in Michael Durante's work include Ocular Oncology and Treatments (12 papers), Cancer Genomics and Diagnostics (8 papers) and Multiple Myeloma Research and Treatments (7 papers). Michael Durante is often cited by papers focused on Ocular Oncology and Treatments (12 papers), Cancer Genomics and Diagnostics (8 papers) and Multiple Myeloma Research and Treatments (7 papers). Michael Durante collaborates with scholars based in United States, Panama and Canada. Michael Durante's co-authors include J. William Harbour, Stefan Kurtenbach, Christina L. Decatur, Jeffim N. Kuznetsov, Daniel A. Rodriguez, Matthew G. Field, Margaret I. Sanchez, Alan S. Livingstone, Lynn G. Feun and Helen Snyder and has published in prestigious journals such as Nature Communications, Blood and Nature Neuroscience.

In The Last Decade

Michael Durante

31 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Single-cell analysis reveals new evolutionary complexity in uveal melanoma

2020 295 citations Michael Durante, Daniel A. Rodriguez et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Durante United States	14	621	392	337	304	182	33	1.1k
Christina L. Decatur United States	13	659 1.1×	748 1.9×	427 1.3×	447 1.5×	168 0.9×	30	1.3k
L. M. Gardner United States	13	497 0.8×	145 0.4×	138 0.4×	305 1.0×	110 0.6×	13	1.0k
Andrew P. Voigt United States	17	697 1.1×	411 1.0×	148 0.4×	235 0.8×	84 0.5×	41	1.2k
Morgan O’Hayre United States	14	927 1.5×	52 0.1×	421 1.2×	285 0.9×	141 0.8×	18	1.5k
Barry L. Burgess United States	18	504 0.8×	425 1.1×	141 0.4×	268 0.9×	31 0.2×	29	883
Mélanie Letexier France	12	1.3k 2.1×	271 0.7×	304 0.9×	97 0.3×	432 2.4×	17	2.0k
Diego Ottaviani United Kingdom	15	570 0.9×	31 0.1×	179 0.5×	134 0.4×	89 0.5×	35	935
Xinzheng V. Guo United States	12	470 0.8×	78 0.2×	220 0.7×	200 0.7×	98 0.5×	19	830
Joan Anton Puig‐Butillé Spain	20	601 1.0×	26 0.1×	794 2.4×	165 0.5×	195 1.1×	60	1.3k

Countries citing papers authored by Michael Durante

Since Specialization

Citations

This map shows the geographic impact of Michael Durante's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Durante with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Durante more than expected).

Fields of papers citing papers by Michael Durante

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Durante. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Durante. The network helps show where Michael Durante may publish in the future.

Co-authorship network of co-authors of Michael Durante

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Durante. A scholar is included among the top collaborators of Michael Durante based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Durante. Michael Durante is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kazandjian, Dickran, Benjamin Diamond, Romanos Sklavenitis‐Pistofidis, et al.. (2024). Genomic Profiling to Contextualize the Results of Intervention for Smoldering Multiple Myeloma. Clinical Cancer Research. 30(19). 4482–4490. 5 indexed citations

Lee, Holly, Michael Durante, Sheri Skerget, et al.. (2024). Impact of soluble BCMA and non–T-cell factors on refractoriness to BCMA-targeting T-cell engagers in multiple myeloma. Blood. 144(25). 2637–2651. 16 indexed citations

Kurtenbach, Stefan, Margaret I. Sanchez, Daniel A. Rodriguez, et al.. (2023). PRAME induces genomic instability in uveal melanoma. Oncogene. 43(8). 555–565. 13 indexed citations

Diamond, Benjamin, Dickran Kazandjian, Bachisio Ziccheddu, et al.. (2023). Genomic Profiling to Interpret the Outcomes of Early Intervention for High-Risk Smoldering Myeloma. Blood. 142(Supplement 1). 757–757. 1 indexed citations

Field, Matthew G., James J. Dollar, Michael Durante, et al.. (2022). RB1 loss triggers dependence on ESRRG in retinoblastoma. Science Advances. 8(33). eabm8466–eabm8466. 13 indexed citations

Faião‐Flores, Fernanda, Michael F. Emmons, Biswarup Saha, et al.. (2022). HDAC11 activity contributes to MEK inhibitor escape in uveal melanoma. Cancer Gene Therapy. 29(12). 1840–1846. 4 indexed citations

Kurtenbach, Stefan, et al.. (2021). Uphyloplot2: visualizing phylogenetic trees from single-cell RNA-seq data. BMC Genomics. 22(1). 419–419. 24 indexed citations

Alsina, Katherina M., Lauren Meldi Sholl, Kyle R. Covington, et al.. (2021). Analytical Validation and Performance of a 7-Gene Next-Generation Sequencing Panel in Uveal Melanoma. Ocular Oncology and Pathology. 7(6). 428–436. 2 indexed citations

Rodriguez, Daniel A., Jessica Yang, Michael Durante, et al.. (2021). Multiregional genetic evolution of metastatic uveal melanoma. npj Genomic Medicine. 6(1). 70–70. 8 indexed citations

10.

Kurtenbach, Stefan, et al.. (2021). PieParty: visualizing cells from scRNA-seq data as pie charts. Life Science Alliance. 4(5). e202000986–e202000986. 2 indexed citations

11.

Hatzistergos, Konstantinos E., Michael Durante, Krystalenia Valasaki, et al.. (2020). A novel cardiomyogenic role for Isl1 ⁺ neural crest cells in the inflow tract. Science Advances. 6(49). 14 indexed citations

12.

Durante, Michael, Stefan Kurtenbach, Zoukaa Sargi, et al.. (2020). Single-cell analysis of olfactory neurogenesis and differentiation in adult humans. Nature Neuroscience. 23(3). 323–326. 147 indexed citations

13.

Rodriguez, Daniel A., et al.. (2020). Novel Long Non-Coding RNAs Associated with BAP1 Mutations in Uveal Melanoma. Investigative Ophthalmology & Visual Science. 61(7). 4023–4023. 1 indexed citations

14.

Durante, Michael, Daniel A. Rodriguez, Stefan Kurtenbach, et al.. (2020). Single-cell analysis reveals new evolutionary complexity in uveal melanoma. Nature Communications. 11(1). 496–496. 295 indexed citations breakdown →

15.

Faião‐Flores, Fernanda, Michael F. Emmons, Michael Durante, et al.. (2019). HDAC Inhibition Enhances the In Vivo Efficacy of MEK Inhibitor Therapy in Uveal Melanoma. Clinical Cancer Research. 25(18). 5686–5701. 69 indexed citations

16.

Kuznetsov, Jeffim N., Tristan Agüero, Stefan Kurtenbach, et al.. (2019). BAP1 regulates epigenetic switch from pluripotency to differentiation in developmental lineages giving rise to BAP1-mutant cancers. Science Advances. 5(9). eaax1738–eaax1738. 65 indexed citations

17.

Durante, Michael, Matthew G. Field, Margaret I. Sanchez, et al.. (2019). Genomic evolution of uveal melanoma arising in ocular melanocytosis. Molecular Case Studies. 5(4). a004051–a004051. 10 indexed citations

18.

Stathias, Vasileios, Michele Forlin, Winston Walters, et al.. (2018). Drug and disease signature integration identifies synergistic combinations in glioblastoma. Nature Communications. 9(1). 5315–5315. 67 indexed citations

19.

Field, Matthew G., Michael Durante, Hima Anbunathan, et al.. (2018). Punctuated evolution of canonical genomic aberrations in uveal melanoma. Nature Communications. 9(1). 116–116. 130 indexed citations

20.

Zhao, Dekuang, Seth A. Wander, Jia Sun, et al.. (2015). Cytoplasmic p27 promotes epithelial–mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation. Oncogene. 34(43). 5447–5459. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact